Online Fatigue Intervention Program for People With Scleroderma (FAME-ISS)
Primary Purpose
Systemic Sclerosis
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
online fatigue intervention
Sponsored by
About this trial
This is an interventional other trial for Systemic Sclerosis
Eligibility Criteria
Inclusion Criteria:
- Resident of the United States
- Diagnosis of systemic scleroderma
- 18 years of age or older
- Have use of a device with internet and email access, and video conferencing capabilities (both audio and visual)
- Communicate in English
- Have fatigue (combined score of >12 on 3 questions that rate degree of fatigue, severity of fatigue, and level of stress caused by fatigue on a scale from 1 - 10)
- Be willing and available to complete the study protocol which consists of attending a 1.5 hour virtual meeting once a week for 6 weeks.
Exclusion Criteria:
- Pregnancy
- Not having use of a device with internet, email access, and video conferencing capabilities (both audio and visual)
- Not able to communicate in English
- Score < 12 on the fatigue screening questions
- Not willing or not able to complete the study protocol or participate in the program at the designated times and days.
Sites / Locations
- University of New Mexico
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Fatigue intervention
Arm Description
the Fatigue intervention is a 6 week intervention delivered using video teleconferencing
Outcomes
Primary Outcome Measures
Change from baseline Modified Fatigue Impact Scale at 6 weeks
self report of impact of fatigue on physical, cognitive and psychosocial functioning
Change from baseline Multidimensional Assessment of Fatigue at 6 weeks
Measures four subjective domains of fatigue: degree and severity, amount of distress it causes, timing, and degree to which fatigue interferes with the activities of daily living
Secondary Outcome Measures
Full Information
NCT ID
NCT04401943
First Posted
May 13, 2020
Last Updated
June 15, 2023
Sponsor
University of New Mexico
Collaborators
University of California, San Diego
1. Study Identification
Unique Protocol Identification Number
NCT04401943
Brief Title
Online Fatigue Intervention Program for People With Scleroderma
Acronym
FAME-ISS
Official Title
Pilot Study of an Online Fatigue Intervention Program for People With Scleroderma
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 13, 2020 (Actual)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
August 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of New Mexico
Collaborators
University of California, San Diego
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This research is being done to evaluate if an online fatigue intervention program will decrease fatigue, pain and increase confidence managing fatigue and being able to do daily tasks. This study involves competing a series of questionnaires before and after the intervention , and attending and participating in the online videoconference fatigue program for 1 1/2 hour meetings each week over a 6-week period of time.
Detailed Description
If eligible and give consent, participants will be asked to complete 2 online questionnaires. The first questionnaire asks basic information such as your age, gender, educational level, and amount of time diagnosed with systemic sclerosis. The second questionnaire asks about your disease symptoms.
You will also be asked to complete questionnaires about your fatigue, pain, mood, confidence in managing your disease and performing daily tasks, and knowledge and use of energy saving techniques.
Once you compete the questionnaires, you will be asked to compete a survey about times and days you would be available to attend the online videoconference fatigue program meeting over a 6 week period of time.
Once the time and dates for the fatigue program are scheduled, you will be expected to attend and take part (using visual and audio) in each 1 ½ hour meeting for 6 weeks online.
The fatigue program includes information on causes of fatigue, ways to protect joint and save energy, ways to manage stress, pain, good eating habits, and exercise. Outside of meetings, you will also be expected to do any "homework" assignments in between the group meetings such as setting goals and doing activities to reach your goals.
At the end of the 6 weeks, you will be asked to complete the same questionnaires you did at the beginning of the study regarding, fatigue, pain, and ability to perform daily tasks. You will also be asked to complete an evaluation of the course.
3 months later, you will be asked to take part in a 45 minute telephone interview to talk about your fatigue and how you are using the ideas from the program.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Systemic Sclerosis
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
12 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Fatigue intervention
Arm Type
Experimental
Arm Description
the Fatigue intervention is a 6 week intervention delivered using video teleconferencing
Intervention Type
Other
Intervention Name(s)
online fatigue intervention
Intervention Description
on line teleconferencing fatigue intervention for 6 weeks on causes of fatigue, ways to protect joint and save energy, ways to manage stress, pain, good eating habits, and exercise.
Primary Outcome Measure Information:
Title
Change from baseline Modified Fatigue Impact Scale at 6 weeks
Description
self report of impact of fatigue on physical, cognitive and psychosocial functioning
Time Frame
baseline, 6 weeks
Title
Change from baseline Multidimensional Assessment of Fatigue at 6 weeks
Description
Measures four subjective domains of fatigue: degree and severity, amount of distress it causes, timing, and degree to which fatigue interferes with the activities of daily living
Time Frame
baseline, 6 weeks
Other Pre-specified Outcome Measures:
Title
Change from baseline Hospital Anxiety and Depression Scale at 6 weeks
Description
Measures anxiety and depression
Time Frame
baseline, 6 weeks
Title
Change from baseline PROMIS Self-Efficacy for Managing Symptoms at 6 weeks
Description
Measures participants' confidence in managing symptoms so as not to interfere with the activities they perform in day to day life.
Time Frame
baseline, 6 weeks
Title
Change from baseline Self-Efficacy for Performing Energy Conservation Strategies Assessment at 6 weeks
Description
Measures participants' confidence in their ability to use energy conservation strategies
Time Frame
baseline, 6 weeks
Title
Energy Conservations Strategies Survey
Description
Measures people's use of energy conservation strategies
Time Frame
6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Resident of the United States
Diagnosis of systemic scleroderma
18 years of age or older
Have use of a device with internet and email access, and video conferencing capabilities (both audio and visual)
Communicate in English
Have fatigue (combined score of >12 on 3 questions that rate degree of fatigue, severity of fatigue, and level of stress caused by fatigue on a scale from 1 - 10)
Be willing and available to complete the study protocol which consists of attending a 1.5 hour virtual meeting once a week for 6 weeks.
Exclusion Criteria:
Pregnancy
Not having use of a device with internet, email access, and video conferencing capabilities (both audio and visual)
Not able to communicate in English
Score < 12 on the fatigue screening questions
Not willing or not able to complete the study protocol or participate in the program at the designated times and days.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Janet L Poole, PhD
Organizational Affiliation
University of New Mexico
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of New Mexico
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87131-0001
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
35124888
Citation
Carandang K, Poole J, Connolly D. Fatigue and activity management education for individuals with systemic sclerosis: Adaptation and feasibility study of an intervention for a rare disease. Musculoskeletal Care. 2022 Sep;20(3):593-604. doi: 10.1002/msc.1617. Epub 2022 Feb 6.
Results Reference
derived
Learn more about this trial
Online Fatigue Intervention Program for People With Scleroderma
We'll reach out to this number within 24 hrs